Determinants of Frailty Among of Informal Caregivers of Demented Patient
NCT ID: NCT03994562
Last Updated: 2023-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2019-02-08
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determinant of the Risk of the Becoming Frail in the Non-dependent Elederly
NCT04012840
Frailty Outcomes And Risk With Alzheimer's Related Dementia
NCT06570109
Are the Fried Criteria Predictive of a Functional Decline in Older People With Solid Malignant Tumors?
NCT02662179
Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome
NCT02288221
Identification of Frailty Predictors of Adverse Health Outcomes in Community-dwelling Individuals Aged 50 and Over
NCT04603144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fried's criteria are the more commonly used criteria to diagnose frailty :
* Loss of weight \> 4.5 kg over one year,
* Self-reported exhaustion,
* Low muscle strength (handgrip \<20% norm for age and sex),
* Low physical activity
* Low gait speed (\<0.8m/s). According to the number of Fried's criteria, subjects are considered frail (≥ 3 Fried's criteria), pre-frail (1-2 Fried's criteria) or robust (0 Fried's criterion).
A large proportion of care is believed to be delivered by informal caregivers (e.g., spouses, next of kin). The caregivers' burden experienced as "enduring stress and frustration" due to caregiving, affects caregivers' mental health with depression, anxiety and sleep disorders, increases caregivers' morbidity and mortality. Multi-interventional studies (including physical and psychological wellbeing) have proven their accuracy to improve quality of life of caregivers.
In France, caregivers (\>60 years) of demented people number have been estimate to 3.3 million (DREES).
For more than one year, in the Broca memory center (3000 patients/ years), caregivers can benefit from a comprehensive medico-psychosocial assessment during a day care hospital. Frailty is assessed in usual care. Two caregivers a week benefit from this assessment. The same day care hospital has been implemented in the "Paul Brousse" hospital (100 patients/year) : One caregiver a week benefit from this assessment.
Main objective:
To assess the relationship between frailty among informal caregivers of demented patients and the caregiver's burden (Zarit scale).
Secondary objective:
To assess determinants of frailty among caregivers.
Main outcome :
Caregiver burden will be determined according to the Zarit scale. The Zarit scale is an auto-questionnaire which includes 22 questions (rated from 0 to 4 points) and scores out of 88. A higher score reflects a higher caregiver burden.
Frailty will be defined by Fried criteria. Subjects will be considered as frail (≥ 3 Fried's criteria), pre-frail (1-2 Fried's criteria) or robust (0 Fried's criteria).
Secondary outcomes
* Age, sex, educational level
* Treatments et polypharmacy (≥ 4 treatments)
* Neuropsychological test if cognitive complaint : caregivers will be categorized as cognitively normal, mild cognitive impairment or dementia.
* Depression according to the Pichot scale and the Geriatric Depression Scale.
* Anxiety according to the Goldberg scale
* Nutritional Assessment: mini nutritional assessment and body mass index.
Feasibility :
Eighty caregivers will be included in the Broca hospital and 40 in the Paul Brousse hospital. To reach the calculated number of subjects to include (n=120), inclusions will take place during 1 year and a half.
Statistical analysis
Main objective :
To disclose a difference in the Zarit score of 11 points (retrospective analysis of collected data) with 80% power and α 5% risk, 120 subjects have to be included. The population will be described and factors associated with the Zarit scale in uni-variate analysis will be studied in a multiple linear regression model.
Analysis will be also performed according to 3 groups: frail, pre-frail and robust.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over \> 65 years old,
* who accept exhaustive evalutaion in day care hospital, who agree for ther data to be recorded (anonymously) for an observational study
Exclusion Criteria
* People under tutorship
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gérond'if
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuelle Duron, Md, PHd
Role: PRINCIPAL_INVESTIGATOR
APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Broca Hospital
Paris, Ile de Frane, France
Paul Brousse Hospital
Villejuif, Val De Marne, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02925-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.